Takeda's TAKHZYRO® (lanadelumab) Approved in Japan for Prophylaxis Against Acute Attacks of Hereditary Angioedema (HAE)
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
Japan Specific Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Japan Specific Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Japan Specific Phase Today - Breaking & Trending Today